Profil
Charlie Yang currently works at Novartis AG, as Director-Therapeutic Area Strategy from 2025.
Dr. Yang also formerly worked at Morgan Stanley & Co. LLC, as Research Associate from 2019 to 2022 and BofA Securities, Inc., as Research Analyst from 2022 to 2025.
Dr. Yang received his undergraduate degree in 2008 from the University of California and graduate degree in 2010 and doctorate degree in 2016 from Boston University School of Medicine.
Postes actifs de Charlie Yang
| Sociétés | Poste | Début |
|---|---|---|
| NOVARTIS AG | Corporate Officer/Principal | 01/07/2025 |
Anciens postes connus de Charlie Yang
| Sociétés | Poste | Fin |
|---|---|---|
BofA Securities, Inc.
BofA Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/01/2025 |
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Analyst-Equity | 01/07/2022 |
Formation de Charlie Yang
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Morgan Stanley & Co. LLC
Morgan Stanley & Co. LLC Investment Banks/BrokersFinance Provides brokerage services | Finance |
Novartis AG
Novartis AG Pharmaceuticals: MajorHealth Technology Manufactures and markets health care and nutritional products | Health Technology |
University of California
University of California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Boston University School of Medicine
Boston University School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BofA Securities, Inc.
BofA Securities, Inc. Investment Banks/BrokersFinance Provides brokerage services | Finance |
















